Raman Prakash 4

What Happened Raman Prakash, a director of Olema Pharmaceuticals, was granted a derivative award covering 29,500 shares on June 18, 2026. The award is reported at $0.00 per share (total $0.00) on the Form 4 and is an equity grant (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-06-18; Form 4 filed: 2026-06-23 (filing appears late vs. the typical two-business-day Form 4 window).
• Transaction type/code: A (award/grant of derivative securities); shares reported: 29,500; price reported: $0.00.
• Shares owned after transaction: Not specified in the provided excerpt—see the full Form 4 for beneficial ownership totals.
• Vesting (footnote): The option vests in 12 equal monthly installments beginning 6/18/2026, subject to continuous service; it will vest in full at the issuer’s next annual meeting if not fully vested earlier.

Context This was an equity award (a derivative grant) rather than a purchase or sale—awards are commonly part of compensation or director incentive plans and do not by themselves indicate buying or selling intent. The vesting schedule means the shares become actionable over the next year (or sooner if accelerated per the stated annual-meeting provision).